Bluetongue in endemic or high risk areas
Article 5
1. The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Malta, Austria, Poland, Portugal, Romania, Slovenia, Slovakia and Finland are hereby approved for the period from 1 January 2014 to 31 December 2014. 2. The financial contribution by the Union: (a) shall be at a rate of 50 % of the unit cost defined in points 1(c) and 4(d) of Annex I for: (i) the sampling of domestic animals; (ii) ELISA tests; (iii) PCR tests; (b) shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines up to a maximum of EUR 0,50 on average per dose; (c) shall not exceed the following: (i) EUR 11 000 for Belgium; (ii) EUR 7 000 for Bulgaria; (iii) EUR 70 000 for Germany; (iv) EUR 3 000 for Estonia; (v) EUR 75 000 for Greece; (vi) EUR 590 000 for Spain; (vii) EUR 170 000 for France; (viii) EUR 350 000 for Italy; (ix) EUR 15 000 for Latvia; (x) EUR 8 000 for Lithuania; (xi) EUR 5 000 for Malta; (xii) EUR 5 000 for Austria; (xiii) EUR 25 000 for Poland; (xiv) EUR 125 000 for Portugal; (xv) EUR 35 000 for Romania; (xvi) EUR 13 000 for Slovenia; (xvii) EUR 25 000 for Slovakia; (xviii) EUR 5 000 for Finland.